Pauline Schneider

8PUBLICATIONS
22CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 08, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

Louise Ahlgren, Mattias Pilheden, Helena Sturesson

|Jun 19, 2024
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia.

Fabienne R S Adriaanse, Pauline Schneider, Susan T C J M Arentsen-Peters

|Sep 09, 2023
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia.

Pauline Schneider, Priscilla Wander, Susan T C J M Arentsen-Peters

|Jul 18, 2022
Decitabine mildly attenuates MLL-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizer.

Pauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços

|Mar 25, 2022
High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling.

Priscilla Wander, Susan T C J M Arentsen-Peters, Kirsten S Vrenken

|Jul 25, 2021
Identification and characterization of relapse-initiating cells in MLL-rearranged infant ALL by single-cell transcriptomics.

Tito Candelli, Pauline Schneider, Patricia Garrido Castro

Pageof 2

Frequent Collaborators

3 joint publications

Ronald W Stam

2 joint publications

Sandra S Pinhanços

1 joint publications

Laurence C Cheung

1 joint publications

Rishi S Kotecha